BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29
• 30

• Press Releases

  SELLAS Life Sciences Reaches 80th Event in Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia

  October 28, 2026

   · 

  4 min read
• Press Releases

  Palisade Bio Announces First Patient Dosed in Global Phase 2b ASCENTRA-UC Study Evaluating Once-Daily Oral PALI-2108 for the Treatment of Ulcerative Colitis

  October 28, 2026

   · 

  7 min read
• Press Releases

  RenovoRx to Participate at the Canaccord Genuity MedTech Diagnostics and Digital Health & Services Forum

  October 28, 2026

   · 

  9 min read
• Press Releases

  Tarsus Pharmaceuticals Appoints Neera Clase as Chief Commercial Officer

  October 28, 2026

   · 

  5 min read
• Press Releases

  Propanc Biopharma Advances Clinical Development Preparation for PRP Phase 1b First-In-Human Study in Up to 50 Advanced Cancer Patients

  October 28, 2026

   · 

  5 min read
• Press Releases

  60 Degrees Pharmaceuticals Announces Partnership with The University of Southern Mississippi to Evaluate Castanospermine in Nonclinical Models of Alpha-Gal Syndrome

  October 28, 2026

   · 

  5 min read
• Press Releases

  Medical Care Technologies Inc. (OTCID:MDCE) Highlights Accelerating Revenue Momentum, AI Commercialization and Expanding Subsidiaries

  October 28, 2026

   · 

  5 min read
• Press Releases

  Lupus Research Alliance to Showcase Scientific Advances Across the Research Continuum at ACR Convergence 2026

  October 28, 2026

   · 

  12 min read
• Press Releases

  Median PFS Approaches 14 Months! 3SBio’s PD-1/VEGF Bispecific Antibody Posts Impressive Data at ESMO 2026

  October 28, 2026

   · 

  7 min read
• Press Releases

  Enthorin Therapeutics Announces License Agreement with Rumi Therapeutics for ENT-7340, for Fragile X Syndrome.

  October 28, 2026

   · 

  5 min read